Main Session
Sep
30
SS 36 - GI 3: Liver - checking in on inhibitors, inSPECTing liver function, and making progress oligo-ly
310 - A Phase II Study of Durvalumab and Tremelimumab with Radiation Therapy in Patients with Advanced Hepatocellular Carcinoma and Biliary Tract Cancer
Presenter(s)
Julie Koenig, MD - Mass General Brigham, Somerville, MA